A Two Kinase-Gene Signature Model Using CDK2 and PAK4 Expression Predicts Poor Outcome in Non-Small Cell Lung Cancers

Neoplasma - Slovakia
doi 10.4149/220_150817n448
Full Text
Abstract

Available in full text

Categories
Cancer Research
Date
Authors
Publisher

AEPress, s.r.o.

Related search

A Chromosomal Passenger Complex Protein Signature Model Predicts Poor Prognosis For non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

A 10-Gene Progenitor Cell Signature Predicts Poor Prognosis in Lung Adenocarcinoma

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers

Cancers
Cancer ResearchOncology
2019English

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

Nuclear EGFR Protein Expression Predicts Poor Survival in Early Stage Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2013English

MAP Kinase-Interacting Serine/Threonine Kinase 2 Promotes Proliferation, Metastasis, and Predicts Poor Prognosis in Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2017English

Preoperative Immune-Nutritional Abnormality Predicts Poor Outcome in Elderly Non-Small-Cell Lung Cancer Patients With Comorbidities

Annals of Thoracic and Cardiovascular Surgery
GastroenterologyCardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2020English

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

Molecular Gene Signature and Prognosis of Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy